Want to create an interactive transcript for this episode?
Podcast: Fast Five Medtech News Podcast
Episode: Integra Lifesciences names new CFO, Teleflex recalls Rüsch endotracheal tubes
Description: Teleflex's voluntary recall of its Rüsch endotracheal tubes highlights the possibility of oxygen desaturation, and in the event, any immediate or long-term health consequences depend on the degree and duration of desaturation. Fast Five hosts Sean Whooley and Danielle Kirsh share what issue caused the recall and how many complaints the company has received so far.
The FDA's IDE approval of Metavention's renal denervation therapy represents an important milestone in the treatment of hypertension. Whooley details what the platform does, how it works and how optimistic executives are.
Real-world data validating the efficacy and usability of Bigfoot Biomedical's diabetes m...